Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

The administration of azacitidine (AZA) was found to be more effective than conventional care regimen (CCR) in patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) with lower blast count. We designed a study to determine e...

Descripción completa

Detalles Bibliográficos
Autores principales: Helbig, Grzegorz, Chromik, Karolina, Woźniczka, Krzysztof, Kopińska, Anna J., Boral, Kinga, Dworaczek, Martyna, Koclęga, Anna, Armatys, Anna, Panz-Klapuch, Marta, Markiewicz, Mirosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614132/
https://www.ncbi.nlm.nih.gov/pubmed/30613922
http://dx.doi.org/10.1007/s12253-018-00574-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614132/
https://www.ncbi.nlm.nih.gov/pubmed/30613922
http://dx.doi.org/10.1007/s12253-018-00574-0

Ejemplares similares